Sort
51,570 grants matching “autoimmune disease”
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$975,922Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
IMMUNOGENETICS OF DEMYELINATION
$975,819Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · NS
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$975,704Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$975,699Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · DK
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$975,699Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · DK
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$975,699Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2023 · DK
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
$974,853Jay L Rothstein · Immunext, Inc. · R44 · FY2022 · AI
NIAMS Multidisciplinary Clinical Research Center
$974,754Robert P Kimberly · University Of Alabama At Birmingham · P60 · FY2012 · AR
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$974,750Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI
Rapid quantification of nuclear citrullination in human neutrophils
$974,659Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2022 · AI
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$974,635Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
$974,213Allan D. Kirk · Duke University · U19 · FY2020 · AI
AUTOIMMUNE ARTHRITIS--GENETICS AND CELLULAR REGULATION
$973,964Rush University Medical Center · P01 · FY2001 · AR
Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis
$973,917Ashkan Vaziri · Biosensics, Llc · R44 · FY2025 · NS
HLA and KIR Genomics in Inflammatory Bowel Disease
$973,852Elizabeth A Trachtenberg · Children'S Hospital & Res Ctr At Oakland · U01 · FY2010 · AI
Studies Of Hereditary Neurological Disease: Disease Gene Identification
$973,500Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Autoimmunity: Mechanisms of Unresponsiveness
$973,295Stanford University · P01 · FY2004 · AI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)
$973,155Stanley G Nathenson · Albert Einstein College Of Medicine · U01 · FY2010 · GM
The TEDDY Study: Georgia/Florida Clinical Center
$972,804Jin-Xiong She · Augusta University · U01 · FY2010 · DK
Diabetes Perdiction in Skane(DiPiS)
$972,581Ake Lernmark · University Of Washington · U01 · FY2006 · DK
Novel Chemistry to Monitor and Manipulate the Immune System
$972,500Thomas J. Kodadek · Scripps Florida · DP1 · FY2010 · OD
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$972,337Janet T. Holbrook · Johns Hopkins University · UG1 · FY2022 · EY
SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate Bleeding in Thrombocytopenia
$972,163Michael Arthur Bruckman · Haima Therapeutics, Llc · R44 · FY2024 · HL
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$972,063Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2022 · DE
The Environmental Triggers of Diabetes (TEDDY) in Sweden
$972,009Ake Lernmark · Lunds Universitet · U01 · FY2021 · DK